OUR MISSION
ChemClarityis a 501c3 nonprofit initiative designing tools and services to guide physicians and designers alike through the complex chemical landscape.
The goal is to accelerate the recognition of chemical related symptoms to avoid illness and of where to locate harmful chemicals in the indoor environment to remove them.
We are grateful to the CDC’s National Institute for Occupational Safety & Health (NIOSH) and the Environmental Protection Agency (EPA) for their sincere interest in supporting private startups like ChemClarity with their expertise & data.
ChemClarity’s mission is to provide non-scientists with:
The knowledge to identify harmful chemicals in products and building materials;
To recognize chemical-related illnesses;
And to navigate to an understanding of which chemicals could potentially impact a patient’s health.
OUR VISION
There are 1.1 million physicians and 1.6 million real estate developers, architects and interior designers in the U.S. on the front lines of seeing chemical impacts on human health in buildings. Doctors are the first step in a diagnostic chain in which patients are rarely diagnosed, because of the disconnect between science, toxicology and general practitioners. Designers guide their clients to healthier indoor environments.
ChemClarity is designing tools and services to guide non-scientists through the complex chemical landscape. The goal is to accelerate the recognition of chemical related illnesses and of where to locate harmful chemicals in the indoor environment.
Risk management is ChemClarity’s goal - find and remove the source of the problem to avoid illness. ChemClarity presents complex scientific data about chemicals with an actionable logic. Like other NGOs in the industry, ChemClarity also provides information to assist doctors and designers in proactively eliminating harmful chemicals in order to avoid legislation and litigation.
THE CHALLENGE
The increasing number of chemical related illnesses:
According to the World Health Organization, the health impact of chemicals in 2016 was “1.6 million lives and 45 million disability-adjusted life years lost”. In the U.S. from 1997-2008, childhood developmental disabilities increased 17% (1.8 million children). Asbestos related deaths from Mesothelioma Cancer between 1999-2013 were estimated to be over 189,000.
The gap in the number of chemicals developed and the number banned by Federal Regulations:
There are 86,718 chemicals in commercial use today in the U.S. and over 1,200,000 chemicals used since the 1930s. There are 3,689 chemicals typically found outdoors that are prohibited by Federal Statutes (Clean Air, Clean Water, CERCLA and RCRA), with individual chemicals added to the list monthly.
ChemClarity aggregated the databases from the CDC and EPA totaling over 1.2 million chemicals to aid in decision making for physicians and designers.
The challenge of our generation is understanding which chemicals are of concern, how to find and remove them, and how to test and treat patients.
What differentiates ChemClarity?
Our AI-driven tool combines data from EPA and CDC databases to perform the analysis for non-scientists.
Our tool categorizes chemicals by symptoms/illnesses/body systems and by chemical ingredient/product/product family.
Our goal is to eliminate the sources of chemicals, to remove them quickly from patients & buildings.
ChemClarity helps identify chemicals that cause chronic and acute illnesses.
THE CHEMCLARITY SOLUTION
ChemClarity enables the real estate and medical communities to recognize chemical related illnesses and expedite chemical exposure hypotheses to effectively treat patients and remediate buildings.
ChemClarity and its Strategic Partners are improving the recognition of symptoms and access to testing for buildings and patients.
“ChemClarity is integrating EPA and CDC datasets with a structured taxonomy and decision-tree approach with questions about their building and health to derive a list of potential chemical causes of health issues.
Community is the leverage that will reduce chemical related illnesses more quickly, so ChemClarity Community is developing a platform that connects clients with toxicologists, medical toxicologists, industrial hygienists and research scientists as resources for testing and more specific recommendations. ”